These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2758373)

  • 1. Inhibition of platelet-activating factor induced renal hemodynamic and tubular dysfunctions with L-655,240, a new thromboxane-prostaglandin endoperoxide antagonist.
    Hébert RL; Sirois P; Plante GE
    Can J Physiol Pharmacol; 1989 Apr; 67(4):304-8. PubMed ID: 2758373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of PAF-acether on the dog kidney.
    Hébert RL; Sirois P; Braquet P; Plante GE
    Prostaglandins Leukot Med; 1987 Mar; 26(3):189-202. PubMed ID: 3033688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
    Yoo J; Schlondorff D; Neugarten J
    J Pharmacol Exp Ther; 1990 May; 253(2):743-8. PubMed ID: 2140130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of platelet activating factor in the dog kidney in vivo.
    Scherf H; Nies AS; Schwertschlag U; Hughes M; Gerber JG
    Hypertension; 1986 Sep; 8(9):737-41. PubMed ID: 3744467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor and solute transport processes in the kidney.
    Handa RK; Strandhoy JW; Giammattei CE; Handa SE
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F274-81. PubMed ID: 12529272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of platelet-activating factor in renal function in normal rats and rats with bilateral ureteral obstruction.
    Reyes AA; Klahr S
    Proc Soc Exp Biol Med; 1991 Oct; 198(1):572-8. PubMed ID: 1891471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotoxicity of cyclosporine: the role of platelet-activating factor and thromboxane.
    dos Santos OF; Boim MA; Barros EJ; Pirotzky E; Braquet P; Schor N
    Lipids; 1991 Dec; 26(12):1320-3. PubMed ID: 1819724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of PAF-acether.
    Plante GE; Hebert RL; Lamoureux C; Braquet P; Sirois P
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():173-9. PubMed ID: 3774843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rC5a on the circulation of normal and split hydronephrotic rat kidneys.
    Gulbins E; Schlottmann K; Rauterberg EW; Steinhausen M
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F96-103. PubMed ID: 8342619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide inhibition does not prevent the hypotensive response to increased renal perfusion in rabbits.
    Thomas CJ; Anderson WP; Woods RL
    Clin Exp Pharmacol Physiol; 1995 May; 22(5):345-51. PubMed ID: 7554426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure.
    Lahera V; Salom MG; Miranda-Guardiola F; Moncada S; Romero JC
    Am J Physiol; 1991 Dec; 261(6 Pt 2):F1033-7. PubMed ID: 1750517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between prostaglandin E2 and leukotriene D4 on the excretion of electrolytes by the dog kidney in vivo.
    Hébert RL; Lamoureux C; Sirois P; Braquet P; Plante GE
    Prostaglandins; 1987 Feb; 33(2):301-13. PubMed ID: 3473574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
    Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of phospholipids on renal function.
    Buckalew VM; Strandhoy JW; Handa RK
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S79-81. PubMed ID: 7508037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK; Strandhoy JW; Handa SE
    Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal vascular and sympathetic nerve responses to hypotension induced by platelet-activating factor in anesthetized dogs.
    Matsuda Y; Shibamoto T; Hayashi T; Saeki Y; Yamaguchi Y; Tanaka S; Koyama S
    Eur J Pharmacol; 1993 Dec; 250(3):341-7. PubMed ID: 8112393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs.
    Yatsu T; Arai Y; Takizawa K; Kasai-Nakagawa C; Takanashi M; Uchida W; Inagaki O; Tanaka A; Asano M; Honda K; Takenaka T
    Eur J Pharmacol; 1997 Mar; 322(1):45-53. PubMed ID: 9088869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal interstitial hydrostatic pressure during verapamil-induced natriuresis.
    Granger JP; Solhaug MJ
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R432-6. PubMed ID: 1558213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of diltiazem and nifedipine on renal function in the rat.
    Johns EJ
    Br J Pharmacol; 1985 Mar; 84(3):707-13. PubMed ID: 3986432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor is a renal vasodilator in the anesthetized rat.
    Handa RK; Strandhoy JW; Buckalew VM
    Am J Physiol; 1990 Jun; 258(6 Pt 2):F1504-9. PubMed ID: 2360650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.